Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Getting UK market access right

The importance of a local value story in UK Market Access - practical insights on how to ensure product adoption in the UK

- PMLiVE

EMA refuses to back Pfizer’s Xeljanz in rheumatoid arthritis

Surprise after approvals in US and Japan

ABPI London offices

ABPI: Pharma must sell outcomes, not products

Annual conference told industry must re-establish its social contract with the NHS

Novartis building

NICE turns down Novartis’ blood cancer drug Jakavi

Uncertainties remain about drug’s cost-effectiveness, according to final draft guidance

Cromos hires Andrey Bazovoy from Quintiles

Joins CRO as director clinical operations

- PMLiVE

AstraZeneca sales hit by Seroquel generics

End of patent exclusivity for antipsychotic among key factors dragging down revenues

- PMLiVE

Boehringer: Move towards trial transparency is “irreversible”

Pharma company plans to publish all scientific data

- PMLiVE

Why does the global data warehouse approach not work?

This webinar will showcase the technical solutions needed to achieve the 'Holy Grail' of aligned global analytics working locally for your countries.

- PMLiVE

Benchmarking product launches via online networks

This free webinar will feature a case study example of how engagement with online communities was instrumental in the success of one company’s new product launch, providing vital information to...

- PMLiVE

Boehringer to restructure in Southern Europe

Closes chemical plant in France as part of plans to “adapt” business structure

- PMLiVE

Boehringer: Tough HTA threatens future of German research

Drug pricing system is stifling innovation says pharma company

- PMLiVE

Novo Nordisk launches new US insulin campaign

US IndyCar driver, diabetic and FlexPen user Charlie Kimball fronts activities

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links